Asterasys
아스테라시스 · 450950
Health Care Medical Devices · KOSDAQ
Market cap US$221.4M (₩305.5B)
Overview
Asterasys makes aesthetic medical devices that tighten and rejuvenate skin without surgery, supplying clinics and hospitals in South Korea and internationally.
Its flagship product, Liftera, uses high-intensity focused ultrasound, a technology that delivers targeted energy beneath the skin, and is designed to reduce treatment discomfort while improving results. Listed on KOSDAQ, South Korea's tech-focused small-cap exchange, the company earns the bulk of its revenue from the Liftera product line while expanding its portfolio with newly approved non-invasive radiofrequency devices.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2024US$20.9M
- FY2025US$27.5M
Operating profit
- FY2024US$4.8M
- FY2025US$7.5M
Net income
- FY2024US$3.9M
- FY2025US$6.7M
Key ratios (FY2025)
Why it matters
New products have received approval from South Korea's MFDS, the national medical-device regulator, and are pursuing separate US FDA clearance to access international markets.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?